Virpax Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Virpax Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2024.
  • Virpax Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 4.25M shares, a 263% increase year-over-year.
  • Virpax Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 4.25M shares, a 263% increase from 2023.
  • Virpax Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.17M shares, a 0.02% increase from 2022.
  • Virpax Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.17M shares, a 82.5% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 4.25M +3.08M +263% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 1.17M +213 +0.02% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 1.17M -5.51M -82.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 6.68M +3.57M +115% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 3.11M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.